Century Therapeutics, Inc. 8-K

What Happened
Century Therapeutics, Inc. filed a Form 8‑K (Item 5.02) reporting that director Carlo Rizzuto, Ph.D., notified the company of his resignation from the Board effective December 18, 2025. The filing states his resignation was not due to any disagreement with the company’s operations, policies or practices, and the company expressed gratitude for his service.

Key Details

• Resignation submitted and effective: December 18, 2025.
• Director: Carlo Rizzuto, Ph.D.
• Reason: Not related to any disagreement with Company on operations, policies or practices (per filing).
• The 8‑K does not identify a replacement director or other immediate board appointments.

Why It Matters
A director resignation is a governance update investors track because it changes board composition and oversight. This filing is a routine disclosure under Item 5.02; investors should watch future filings for any announced replacement or board changes that could affect governance or strategy.